Lucid Diagnostics Inc.

LUCD

Lucid Diagnostics Inc.

LUCD

Insider Sentiment (TTM):

Last Purchase:2026-05-20Last Sale:2023-09-26Shares Purchased (TTM):245,000Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:35,425,902Shares Outstanding:140,096,782Institutional Ownership Pct.:25.29%

Earnings Market Reaction:

Filing Date:2026-08-12Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Cash	33	28	35	47	31	25	22	14	25	25	19	24
Assets Current
Accounts Receivable Net Current	1	1	1	1	0	0	0	0	0	0	0	0
Inventory Net	0	0	0	0	1	0	0	1	1	0	0	-
Prepaid Expense And Other Assets Current	2	2	2	1	2	2	2	2	2	2	3	3
Assets Current	37	31	37	50	34	28	25	17	28	28	22	27
Property Plant And Equipment Net	1	1	1	1	1	1	1	1	1	1	1	1
Operating Lease Right Of Use Asset	1	2	2	2	2	2	3	3	3	1	1	2
Intangible Assets Net Excluding Goodwill	0	0	0	0	1	1	1	1	1	1	1	2
Other Assets Noncurrent	0	0	0	0	1	1	1	1	1	1	1	1
Assets	39	34	40	53	39	33	31	23	34	32	27	33
Liabilities
Liabilities And Stockhold…
Accounts Payable Current	1	1	1	1	1	1	1	1	1	1	1	1
Accrued Liabilities Current	2	2	3	-	-	-	3	-	-	-	-	-
Liabilities Current
Operating Lease Liability Current	1	1	1	1	1	1	1	1	1	1	1	1
Convertible Notes Payable Current	24	25	24	22	25	33	19	10	11	13	14	14
Accounts Payable And Other Accrued Liabilities Cur…	-	-	3	2	2	2	3	2	3	3	4	3
Liabilities Current	28	29	29	26	29	37	24	14	16	20	29	30
Operating Lease Liability Noncurrent	1	1	1	1	1	2	2	2	2	0	0	0
Liabilities	28	30	30	27	31	38	25	16	18	20	30	31
Stockholders Equity
Preferred Stock Value	0	10	54	54	54	54	54	56	56	44	19	14
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	323	292	231	229	201	180	155	143	140	136	130	129
Retained Earnings Accumulated Deficit	-313	-298	-274	-258	-248	-240	-204	-192	-180	-169	-151	-140
Stockholders Equity	11	4	11	26	8	-5	5	6	16	12	-2	3
Liabilities And Stockholders Equity	39	34	40	53	39	33	31	23	34	32	27	33
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	20	20	20	20	20	20	20	20	20	20	20	20
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	400	300	300	300	300	300	300	300	300	200	200	200
Common Stock Shares Issued	191	165	131	131	102	84	63	52	49	47	42	42
Shares Outstanding	191	165	131	131	102	84	63	52	49	47	42	42

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-5.20%	4.90%	-14.51%	-	-	-	-	-	-	-	-	-
2025	8.40%	-13.45%	-15.97%	37.27%	4.21%	21.24%	-7.21%	0.90%	7.21%	5.04%	-16.72%	-19.24%
2024	-18.84%	-16.95%	-20.84%	-4.17%	-3.57%	9.64%	-16.00%	-18.00%	-4.20%	-19.33%	-16.00%	-14.00%
2023	-	-	-	11.11%	-14.48%	-13.13%	18.10%	20.69%	24.14%	-24.81%	-14.62%	-29.43%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	1.33	1.07	1.31	1.90	1.15	0.75	1.07	1.18	1.75	1.38	0.75	0.90
Quick Ratio	1.25	0.97	1.24	1.83	1.07	0.69	0.95	1.02	1.57	1.24	0.64	0.80
Working Capital	9.11M	1.98M	8.89M	23.64M	4.41M	-9.03M	1.62M	2.58M	11.97M	7.61M	-7.31M	-2.92M
Leverage & Debt
Debt to Equity	2.56	7.52	2.70	1.06	3.92	-7.10	4.70	2.57	1.13	1.69	-12.80	12.01
Interest Coverage TTM	-4,223.67	-3,519.07	-2,920.00	-2,000.17	-2,084.30	-2,075.96	-1,771.23	-1,504.37	-250.37	-113.82	-116.54	-128.40
Debt Ratio	0.72	0.88	0.73	0.51	0.80	1.16	0.82	0.72	0.53	0.63	1.08	0.92
Efficiency & Turnover
Asset Turnover TTM	0.10	0.11	0.09	0.12	0.12	0.13	0.15	0.15	0.10	0.07	0.08	0.04
Days Sales Outstanding TTM	67.66	37.71	39.21	24.44	22.31	4.81	3.78	2.61	9.37	4.65	4.66	6.33
Receivables Turnover TTM	5.39	9.68	9.31	14.94	16.36	75.87	96.58	139.63	38.97	78.50	78.32	57.69
Per Share Metrics
Diluted EPS TTM	-	-	-	-0.59	-0.67	-1.01	-1.05	-0.89	-0.97	-1.04	-1.26	-1.36
Free Cash Flow Per Share TTM	-0.26	-0.33	-0.46	-0.29	-0.31	-0.65	-0.88	-0.89	-0.89	-0.85	-0.79	-0.65
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	-	-	-	29.42%	28.76%	63.17%	100.60%	100.72%	104.68%	113.24%	117.13%	151.60%
Operating Profit Margin TTM	-1,286.07%	-1,357.22%	-1,550.28%	-1,091.25%	-1,099.52%	-1,144.19%	-1,059.64%	-1,077.37%	-1,172.76%	-1,507.11%	-1,996.79%	-3,466.93%
Net Profit Margin TTM	-1,485.13%	-1,507.71%	-1,811.68%	-1,460.10%	-1,518.44%	-1,661.18%	-1,220.09%	-1,069.90%	-1,227.76%	-1,576.63%	-2,169.11%	-3,784.27%
Growth Metrics
Net Revenue Growth (1Y)	-9.61%	-13.01%	-26.32%	5.01%	14.74%	39.89%	79.00%	179.27%	379.19%	370.50%	544.03%	165.49%
Net Income Growth (1Y)	-11.59%	-21.05%	9.40%	43.31%	41.90%	47.39%	0.68%	-21.05%	-18.01%	-21.81%	-6.24%	-8.98%
EPS Growth (1Y)	-52.21%	-61.23%	-45.79%	-33.26%	-30.89%	-3.56%	-16.78%	-34.39%	-28.86%	-28.83%	-18.78%	-20.84%
Valuation Metrics
P/E TTM	-3.35	-2.94	-1.92	-1.70	-1.72	-1.48	-0.78	-0.92	-0.85	-0.78	-1.12	-0.86
P/B TTM	17.93	40.28	10.16	4.23	14.48	-19.06	7.67	6.48	2.47	3.07	-25.48	19.16
P/S TTM	49.72	44.38	34.70	24.84	26.11	24.56	9.52	9.80	10.40	12.22	24.25	32.65
Market Cap	195.94M	161.11M	111.12M	109.26M	113.84M	102.51M	41.37M	41.05M	39.53M	36.46M	58.88M	48.98M
Enterprise Value	186.04M	158.44M	100.42M	84.23M	108.01M	110.07M	37.61M	36.77M	25.81M	24.83M	53.93M	39.42M
Calculated Values
Free Cash Flow TTM	-47.64M	-46.40M	-46.65M	-31.47M	-31.11M	-44.44M	-44.49M	-44.60M	-42.85M	-38.31M	-32.83M	-27.11M
Net Debt	-9.90M	-2.68M	-10.71M	-25.03M	-5.82M	7.56M	-3.76M	-4.29M	-13.72M	-11.63M	-4.95M	-9.56M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-05-20Purchase

Owner: Matheis, Dennis

Title: -

Shares: 245,000

Price/Share: $1.00

Value: $245,000.00

Shares Owned: 1,033,443

Relationship: Director

Ownership: Direct

2025-08-20Purchase

Owner: Matheis, Dennis

Title: -

Shares: 100,000

Price/Share: $1.02

Value: $102,000.00

Shares Owned: 665,443

Relationship: Director

Ownership: Direct

2025-05-22Purchase

Owner: Matheis, Dennis

Title: -

Shares: 33,218

Price/Share: $1.32

Value: $43,847.76

Shares Owned: 565,443

Relationship: Director

Ownership: Direct

2023-09-26Sale

Owner: Lapidus, Stanley

Title: -

Shares: 29,747

Price/Share: $1.45

Value: $43,133.15

Shares Owned: 101,592

Relationship: Director

Ownership: Direct

2023-09-21Sale

Owner: Lapidus, Stanley

Title: -

Shares: 100

Price/Share: $1.44

Value: $144.00

Shares Owned: 131,539

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-05-20	Matheis, Dennis	Director	-	Direct	Purchase	245,000	1.00	$245,000.00	1,033,443	4
2025-08-20	Matheis, Dennis	Director	-	Direct	Purchase	100,000	1.02	$102,000.00	665,443	4
2025-05-22	Matheis, Dennis	Director	-	Direct	Purchase	33,218	1.32	$43,847.76	565,443	4/A
2023-09-26	Lapidus, Stanley	Director	-	Direct	Sale	29,747	1.45	$43,133.15	101,592	4
2023-09-21	Lapidus, Stanley	Director	-	Direct	Sale	100	1.44	$144.00	131,539	4/A
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

25.29%

Inst. Shares: 35,425,902

Shares Outstanding: 140,096,782

2025-12-31

31.52%

Inst. Shares: 32,135,589

Shares Outstanding: 101,946,871

2025-09-30

32.43%

Inst. Shares: 35,076,123

Shares Outstanding: 108,176,088

2025-06-30

18.82%

Inst. Shares: 18,628,959

Shares Outstanding: 98,989,161

2025-03-31

13.03%

Inst. Shares: 8,961,233

Shares Outstanding: 68,796,392

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	35,425,902	140,096,782	25.29%
2025-12-31	32,135,589	101,946,871	31.52%
2025-09-30	35,076,123	108,176,088	32.43%
2025-06-30	18,628,959	98,989,161	18.82%
2025-03-31	8,961,233	68,796,392	13.03%
2024-12-31	3,250,237	50,515,773	6.43%
2024-09-30	2,451,644	50,374,146	4.87%
2024-06-30	1,977,682	48,212,040	4.10%
2024-03-31	1,971,521	45,014,410	4.38%
2023-12-31	1,727,778	41,756,129	4.14%
2023-09-30	1,913,241	41,862,805	4.57%
2023-06-30	1,861,825	41,833,823	4.45%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Lucid Diagnostics Inc. (LUCD) — SEC Financial Statements & Analysis

Lucid Diagnostics Inc. (LUCD) is a surgical & medical instruments & apparatus company, incorporated in DE. Lucid Diagnostics Inc. trades on Nasdaq as: LUCD. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Lucid Diagnostics Inc. reported a -9.61% year-over-year revenue growth, a Gross Profit Margin of 29.42% (TTM), a Debt-to-Equity ratio of 2.56x, a Price-to-Sales (P/S) ratio of 49.72x (TTM), a Price-to-Book (P/B) ratio of 17.93x (TTM), at a market cap of $195.94M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -9.61%
Gross Profit Margin TTM: 29.42%
Debt To Equity: 2.56x
P/S TTM: 49.72x
P/B TTM: 17.93x
Market Cap: $195.94M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Lucid Diagnostics Inc. in?

Lucid Diagnostics Inc. (LUCD) operates in the Surgical & Medical Instruments & Apparatus industry.

What is LUCD's market cap?

Lucid Diagnostics Inc. (LUCD) has a market capitalization of $195.94M as of 2026-06-30.

What exchange does LUCD trade on?

Lucid Diagnostics Inc. (LUCD) trades on the Nasdaq.

Where is Lucid Diagnostics Inc. incorporated?

Lucid Diagnostics Inc. is incorporated in DE.